Investor appetite returns as early indications point to Omicron variant being less less severe than initially feared
concerns about the Omicron variant of Covid-19 eased.
ata from SA continues to point to infections of Omicron leading to mild illness, and while cases have surged, patients are requiring less medical intervention. On Tuesday, research from GlaxoSmithKline shows its antibody treatment is effective against the new strain. Some governments are, however, continuing to exercise caution, including the imposition of a vaccine mandate on workers in the private sector and tightening up on preventive measures.
The JSE all share closed 2.71% higher at 72,939.25 points — led by industrial metals , resources , and industrials — and the top 40 was up 2.96%.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
TymeBank picks up Tencent as investor as it eyes emerging-market expansionDigital bank secures investments to complete $180m funding round
Read more »
WATCH: Market ReportBusiness Day TV talks to Thamsanqa Netha from Shiloh Capital
Read more »
JSE faces mixed Asian markets as Omicron threat recedesNew variant is not putting too much pressure on hospitals, while investors are also eyeing monetary policy
Read more »
JSE likely to push higher in line with global marketsAll share index could follow the lead of Wall Street and Asian bourses
Read more »
JSE lifts as equity markets enjoy waning fears of OmicronEarly indications suggest that the effect of the variant is not as severe as initially feared
Read more »
Growing wealth and dreams with BEE share ownership schemesSPONSORED | Sowetan Dialogue discussion hears that schemes available on JSE should be regarded as long-term investments
Read more »